Transcatheter and Surgical Aortic Valve Replacement in Patients With End-Stage Renal Disease

Data on comparative outcomes and readmissions after transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) in patients with end-stage renal disease (ESRD) are scarce because these patients were excluded from major TAVR trials (1). Primary outcomes of interest were...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of the American College of Cardiology 2017-04, Vol.69 (14), p.1875-1876
Hauptverfasser:	Bhise, Viraj, MBBS, MPH, Kanade, Pushkar, MD, MPH, Shantha, Ghanshyam P.S., MD, MPH, Balan, Prakash, MD, Nguyen, Tom C., MD, Loyalka, Pranav, MD, Kar, Biswajit, MD, Estrera, Anthony, MD, Smalling, Richard W., MD, PhD, Dhoble, Abhijeet, MD, MPH
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Aortic valve Aortic Valve - surgery Aortic Valve Stenosis - complications Aortic Valve Stenosis - surgery Blood transfusion Blood transfusions Cardiology Cardiovascular Clinical trials Comorbidity Complications Demographics Demography Electrocardiography End-stage renal disease Female Global Health Heart Valve Prosthesis Hospital costs Humans Implantation Incidence Internal Medicine Kidney diseases Kidney Failure, Chronic - complications Kidney transplantation Male Mortality Patients Postoperative Complications - epidemiology Risk Factors Surgery Survival Rate - trends Transcatheter Aortic Valve Replacement - methods Transfusion Treatment Outcome
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Data on comparative outcomes and readmissions after transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) in patients with end-stage renal disease (ESRD) are scarce because these patients were excluded from major TAVR trials (1). Primary outcomes of interest were in-hospital mortality, in-hospital complications (permanent pacemaker implantation and blood transfusion), post-procedure length of stay, discharge disposition, cost of hospitalization, and 30-day readmission rates. Table 1Pre- and Post-Propensity−Matched Baseline Demographics and Outcomes Comparing TAVR and SAVR in ESRD PatientsValues are % unless otherwise indicated.ESRD = end-stage renal disease; SAVR = surgical aortic valve replacement; TAVR = transcatheter valve replacement. Pre-Propensity Match Post-Propensity Match TAVR (n = 158) SAVR (n = 546) p Value TAVR (n = 119) SAVR (n = 244) p Value Mean age, yrs 76.27 67.08
ISSN:	0735-1097 1558-3597
DOI:	10.1016/j.jacc.2017.01.049